New CEO at Creabilis
This article was originally published in Scrip
Creabilis (Luxembourg), a clinical-stage biotechnology company creating drugs to treat unmet medical needs in serious dermatological diseases, has named Dr Eliot Forster as its new chief executive officer. Dr Forster has almost 20 years' experience in the biotechnology and pharmaceutical industries. He was most recently CEO of the US-based biotech firm Solace Pharmaceuticals. Before that, he was head of EU development and of development operations in the EU and Asia at Pfizer.